Several DOBAQ containing liposomal formulations showed
no knockdown of Factor VII after 48 h following a single
5 mg kgÀ1 injection (Fig. S3w). The inability of ZL systems to
transfect is likely because they are not effectively protonated in
the endosome. However, ZL were generally well tolerated
across multiple liposomal formulations, and did not induce
inflammatory cytokines in vivo (Fig. S4w).
We have described the synthesis and pH-dependent biophysical
behavior of a novel class of ionizable zwitterionic lipids
containing a cationic amine and anionic carboxylate. Structural
variations in the head group were shown to impact the ionization
behavior of ZL; however once the carbon spacer is greater than
one carbon, all ZL show the same general trends. ZL are capable
of forming small, monodisperse liposomes that efficiently
encapsulate siRNA when ionized, and show pH-dependent
zeta potentials ranging from anionic (31 ZL) or neutral (41 ZL)
at physiological pH to cationic at low pH. ZL promote lipid
mixing with anionic vesicles when cationic, and at pH = 4.0,
vesicles containing ZL induce lysis of biomembrane mimicking
vesicles. No membrane disruption was seen with ZL containing
liposomes at physiological pH, and no cytokine induction was
observed in vivo. Structural modifications to increase lipid pKa
may result in zwitterionic lipid systems that efficiently deliver
siRNA while still limiting immune stimulation.
Fig. 4 (a) pH-dependent lipid mixing between ZL liposomes and
anionic liposomes. (b) pH-dependent membrane lysis of anionic
membrane mimicking liposomes by ZL liposomes.
function of pH.15 This provides insight into the fusogenic
potential of ZL, as lipid mixing between the outer membrane
leaflets is a required step in membrane fusion, and may
correlate with their ability to deliver siRNA. ZL are capable
of lipid mixing when cationic (Fig. 4a). Maximum lipid mixing
for all ZL is achieved at pH = 3.5, which corresponds with the
highest zeta potentials. DOBAQ liposomes, which had the
highest zeta potential at all pH o 5.0, show the highest levels
of lipid mixing. DOAAQ, which is not protonated in the range
tested, shows baseline levels of lipid mixing across all tested
pH values. These results agree with published data indicating
that electrostatics drive lipid mixing.6 However, they do
indicate that ZL may not promote endosomal escape because
they do not become cationic at endocytic pH (pH = 5.0–7.0).
Lysis of membrane mimicking anionic vesicles is also used
as a surrogate assay to predict the ability of liposomal systems
to promote endosomal escape.6 We investigated the capacity
of ZL containing liposomes to lyse biomembrane mimicking
vesicles (BMV) encapsulating ANTS/DPX as a function of pH
(Fig. 4b). pH = 4.0 and 7.4 were chosen because previous
experiments confirmed that liposomes containing ZL were
cationic and membrane active at pH = 4.0 but neutral and
inactive at pH = 7.4. ZL liposomes lyse BMV at pH = 4.0 but
cause no lysis at pH = 7.4, indicating they may exhibit
reduced immune stimulation due to their neutral charge at
physiological pH. These results confirm that ZL liposomes
disrupt anionic membranes only when cationic. In this model
system, DOPAT liposomes showed significantly (p o 0.05)
more lysis than all other ZL, indicating that head group
structure may impact membrane lysis.
This work was supported by the NSF Graduate Research
Fellowship Program, NIH–EB003008, Deutsche Forschungs
Gemeinschaft (DGF), and Pfizer.
References
1 V. P. Torchilin, Nat. Rev. Drug Discovery, 2005, 4, 145–160.
2 M. G. Stanton and S. L. Colletti, J. Med. Chem., 2010, 53, 7887–7901.
3 S. C. Semple, A. Akinc, J. Chen, A. P. Sandhu, B. L. Mui, C. K. Cho,
D. W. Y. Sah, D. Stebbing, E. J. Crosley, E. Yaworski, I. M. Hafez,
J. R. Dorkin, J. Qin, K. Lam, K. G. Rajeev, K. F. Wong, L. B. Jeffs,
L. Nechev, M. L. Eisenhardt, M. Jayaraman, M. Kazem, M. A.
Maier, M. Srinivasulu, M. J. Weinstein, Q. Chen, R. Alvarez, S. A.
Barros, S. De, S. K. Klimuk, T. Borland, V. Kosovrasti, W. L.
Cantley, Y. K. Tam, M. Manoharan, M. A. Ciufolini, M. A. Tracy,
A. de Fougerolles, I. Maclachlan, P. R. Cullis, T. D. Madden and
M. J. Hope, Nat. Biotechnol., 2010, 28, 172–176.
4 R. C. Adami, S. Seth, P. Harvie, R. Johns, R. Fam, K. Fosnaugh,
T. Zhu, K. Farber, M. McCutcheon, T. T. Goodman, Y. Liu,
Y. Chen, E. Kwang, M. V. Templin, G. Severson, T. Brown,
N. Vaish, F. Chen, P. Charmley, B. Polisky and M. E. J. Houston,
Mol. Ther., 2011, 19, 1141–51.
5 J. Heyes, L. Palmer, K. Bremner and I. MacLachlan, J. Controlled
Release, 2005, 107, 276–287.
6 J. Zhang, H. Fan, D. A. Levorse and L. S. Crocker, Langmuir,
2011, 27, 1907–14.
7 W. Li and F. C. Szoka, Pharm. Res., 2007, 24, 438–449.
8 L. B. Jeffs, L. R. Palmer, E. G. Ambegia, C. Giesbrecht,
S. Ewanick and I. Maclachlan, Pharm. Res., 2005, 22, 362–372.
9 M. T. Abrams, M. L. Koser, J. Seitzer, S. C. Williams, M. A. DiPietro,
W. Wang, A. W. Shaw, X. Mao, V. Jadhav, J. P. Davide, P. A. Burke,
A. B. Sachs, S. M. Stirdivant and L. Sepp-Lorenzino, Mol. Ther., 2010,
18, 171–180.
Ionized ZL can encapsulate anionic molecules such as
siRNA more efficiently than zwitterionic phospholipids by
exploiting their cationic charge at low pH. DOBAQ, DOPAT,
and DOAAQ were chosen as representative ZL for siRNA
encapsulation experiments using a modified ethanol dilution
method.8 DOBAQ and DOPAT, both of which are cationic at
pH = 4.0, form small, monodisperse liposomes with over 80%
siRNA encapsulation. DOAAQ, which is not ionized at
pH = 4.0 showed less than 5% encapsulation, indicating that
ionized ZL can promote encapsulation of anionic molecules
(Table S2w). This demonstrates the potential utility of the
pH-sensitive characteristics of ZL for encapsulating multivalent
anionic drugs in small, neutral particles by modulating the
pH of the system during encapsulation. DOBAQ : DOPE
(65 : 35) liposomes showed no siRNA knockdown of luciferase
(ZL : siRNA ratio (w : w) = 15 or 30; 90 or 180 nM siRNA)
in stably transfected HeLa-Luc cells in vitro (Fig. S2w).
10 A. G. Kohli, C. L. Walsh and F. C. Szoka, Chem. Phys. Lipids,
2012, 165, 252–259.
11 E. K. Perttu, A. G. Kohli and F. C. Szoka, J. Am. Chem. Soc.,
2012, 134, 4485–4488.
12 E. K. Perttu and F. C. Szoka, Chem. Commun., 2011, 47, 12613–15.
13 O. Zelphati and F. C. Szoka, Proc. Natl. Acad. Sci. U. S. A., 1996,
93, 11493–98.
14 J. Nguyen and F. C. Szoka, Acc. Chem. Res., 2012, DOI: 10.1021/
ar3000162.
15 D. Struck, D. Hoekstra and R. Pagano, Biochemistry, 1981, 20,
4093–99.
c
This journal is The Royal Society of Chemistry 2012
Chem. Commun., 2012, 48, 5575–5577 5577